Northwestern University

Mon 4:00 PM

"Posttranslational Modifications in Carcinogenesis and Therapeutics"

When: Monday, March 19, 2018
4:00 PM - 5:00 PM  

Where: Ward Building, Room 5-230, 303 E. Chicago Avenue, Chicago, IL 60611 map it

Audience: Faculty/Staff - Student - Public - Post Docs/Docs - Graduate Students

Contact: Alexa Nash   312.503.4893

Group: Department of Pharmacology Seminars

Category: Lectures & Meetings


The Department of Pharmacology welcomes Yong Wan, PhD, Professor in the Departments of Obstetrics & Gynecology and Pharmacology at Northwestern University Feinberg School of Medicine.

Posttranslational modifications such as ubiquitination, methylation and ADP-ribosylation orchestrate genome stability, cell division, hormone-initiated signal transduction, apoptosis and tumorigenesis. Posttranslational modifications act as critical molecular switches or fine-tune operators that determine the activation, deactivation or subcellular localization of functional proteins. Emerging evidence has drawn attention to the modulation of regulatory proteins in response to extrinsic/intrinsic signaling being executed simultaneously by multiple posttranslational modifications. Research interests in Wan laboratory seek to address how defects in the ubiquitin-proteasome system (E3 ligase/deubiquitinase), protein methyltransferase and poly (ADP-ribose) polymerase 1 (PARP1) would result in genomic instability, abnormal cell cycle or apoptosis, and aberrant signal transductions that predispose otherwise normal cells to become cancerous tumor cells. The ultimate objective is to integrate our basic research with clinical translational studies that would allow the development of new anti-cancer therapy thereby fully exploiting our knowledge of posttranslational modifications.



Add Event to Calendar

Add Event To My Group:

Please sign-in